Rising drug budgets are tightening formularies and prior authorization processes, as overall prescription drug spending is expected to increase by 9.0-11.0% in 2025
The FDA has approved oral semaglutide for adults with obesity (BMI 30) or overweight adults (BMI 27) who also have at least one weight-related condition, such as: Type 2 diabetes High blood pressure Dyslipidemia Cardiovascular disease risk Dr
As a journalist, Virginia Sole-Smith has reported from kitchen tables, graduated from beauty school, and gone swimming in a mermaids tail
Conversely, certain conditions disqualify patients from semaglutide use
Healthcare providers should also guide on managing post-surgical changes
When you stop taking weight loss injections like semaglutide (Wegovy) or tirzepatide (Zepbound), your body undergoes significant physiological changes as the medication's effects gradually diminish